Régis Peffault de Latour

Research interests

Publications

• Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2308695

• Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2109965

• Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

  Bone Marrow Transplantation · 2022 · https://doi.org/10.1038/s41409-022-01691-w

• Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

  Bone Marrow Transplantation · 2021 · https://doi.org/10.1038/s41409-021-01227-8

• Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

  Bone Marrow Transplantation · 2021 · https://doi.org/10.1038/s41409-021-01227-8

• One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors

  Haematologica · 2021 · https://doi.org/10.3324/haematol.2021.279189

• The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

  Bone Marrow Transplantation · 2020 · https://doi.org/10.1038/s41409-020-0919-0

• Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

  Bone Marrow Transplantation · 2019 · https://doi.org/10.1038/s41409-019-0516-2

• Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT

  Frontiers in Immunology · 2019 · https://doi.org/10.3389/fimmu.2019.01157

• Germline DDX41 mutations define a significant entity within adult MDS/AML patients

  Blood · 2019 · https://doi.org/10.1182/blood.2019000909

• Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study

  Blood · 2018 · https://doi.org/10.1182/blood-2018-09-876805

• Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1502950

• Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience

  Blood · 2013 · https://doi.org/10.1182/blood-2013-01-479733

• Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor Cells

  Cell stem cell · 2012 · https://doi.org/10.1016/j.stem.2012.05.013

• Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

  Blood · 2008 · https://doi.org/10.1182/blood-2008-01-133918

• Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.14.1366

Current projects

No projects listed.